Treatment of cells with 2 μM AZA1 for 24 h significantly reduced cancer cell migration by 59.6 ±12% (22Rv1 cells; p<0.001; Figure 4A), 56.8 ±18.8% (DU 145 cells; p<0.001; Figure S4A) and 57.3 ±16.1% (PC-3 cells; p<0.001; Figure S4A) compared to EGF-stimulated cancer cells. Here, EGF is linked to cancer.